Infusion Pumps & Accessories – FDA Enforcement Policy

The FDA issued a policy to expand the availability and remote capabilities of infusion pumps and accessories used to treat patients who require continuous infusion therapy during the COVID-19 pandemic. Devices included in the policy include infusion pumps, patient-controlled analgesia (PCA) infusion pumps, infusion pump accessories, and infusion safety management software. Learn more by accessing this document.

Please Register or Login

You must be logged in to access exclusive content within our clinical resources.

Register Log-in